FFMMX | NPNCX | FFMMX / NPNCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 15 years | - |
Gain YTD | 4.151 | 3.882 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 104B | 8.61B | 1,208% |
Annual Yield % from dividends | 2.16 | 1.31 | 165% |
Returns for 1 year | 14.46 | 15.84 | 91% |
Returns for 3 years | 19.36 | 8.92 | 217% |
Returns for 5 years | N/A | 51.12 | - |
Returns for 10 years | N/A | 43.82 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBIOX | 19.14 | 0.26 | +1.38% |
Fidelity Select Biotechnology | |||
VSMPX | 275.93 | 1.41 | +0.51% |
Vanguard Total Stock Mkt Idx Instl Pls | |||
BRWCX | 24.72 | 0.10 | +0.41% |
MFS Blended Research Growth Eq C | |||
LMCFX | 35.22 | 0.10 | +0.28% |
Lord Abbett Mid Cap Stock F | |||
QSERX | 17.70 | 0.05 | +0.28% |
AQR Small Cap Multi-Style R6 |